Patent details
LUC00113 Product Name: Doravirine ou un sel pharmaceutiquement acceptable de celle-ci
Basic Information
- Publication number:
- LUC00113
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP117618561
- Legal Status:
- Inactive
- Application number:
- LUC00113
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
1
- Marketing Authorization Number:
- EU/1/18/1333
- Marketing Authorization Type:
- Marketing Authorization Date:
- 26/11/2018
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
2
- Marketing Authorization Number:
- EU/1/18/1332
- Marketing Authorization Type:
- Marketing Authorization Date:
- 27/11/2018
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 17/04/2019
- First Marketing Authorization date:
- 26/11/2018
- Grant date:
- 22/05/2024
- Activation date:
- Publication date:
- 17/04/2019
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 26/11/2033
- SPC Extension Expiration:
- 26/11/2033
- Rejection date:
- Withdrawal date:
Owner
- From:
- 17/04/2019
- Name:
- Merck Canada Inc.
- Address:
- 16711 Trans-Canada Highway, Kirkland QC H9H 3L1, Canada (CA)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 17/04/2019
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2019/06
- Publication date:
- 06/05/2019
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2024/07
- Publication date:
- 03/06/2024
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
3
- Bulletin Heading:
- SPC4
- Bulletin edition number:
- 2024/09
- Publication date:
- 11/07/2024
- Description:
- Section F : Correction of granted supplementary protection certificates – I9 publication
Annual Fees
- Annual Fee Due Date:
- 31/03/2031
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 17/04/2019 | Outgoing Correspondence | 1 |
| 17/04/2019 | General Document | 3 |
| 17/04/2019 | General Document | 2 |
| 17/04/2019 | General Document | 38 |
| 17/04/2019 | Application Form | 4 |
| 23/05/2024 | Outgoing Correspondence | 1 |
| 17/04/2019 | Publication | 1 |
| 22/05/2024 | Publication | 1 |
| 22/05/2024 | Certificate | 1 |
| 06/06/2024 | Marketing authorization | 3 |
| 06/06/2024 | MA publication | 1 |
| 07/06/2024 | Incoming Correspondence (Post) | 1 |
| 07/06/2024 | Publication | 1 |
| 07/06/2024 | Outgoing Correspondence | 1 |